Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

189

HTML

1571

Tables (1-2)

141

Sum=1901

Jul 14, 2006 (publication date) through Jul 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 14, 2006; 12(26): 4203-4205
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4203

Table 2 Liver serum markers after 3 and 6 mo of termination of one-year regimen in patients who responded to treatment (n=38)

P < 0.04 between 12 mo of and after 6 mo cessation of treatment for ALT, P < 0.03 between 12 mo of and after 6 mo cessation of treatment for AST.

Citation: Alizadeh AHM, Ranjbar M, Karimi B, Hatami S. Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran. World J Gastroenterol 2006; 12(26): 4203-4205
URL: https://www.wjgnet.com/1007-9327/full/v12/i26/4203.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i26.4203